found that semaglutide could reverse the decrease in the levels of tyrosine hydroxylase, alleviate inflammation, and increase autophagy, thus protecting dopaminergic neurons in substantia nigra and striatum (75)
Over a four-month period from November 1, 2024, to March 12, 2025, I tracked my progress using a 3D body scanner and saw the following changes: This was a significant shift, as many people on GLP-1 medications struggle to maintain muscle mass while losing weight
Andrew Huberman That's rough, right
However, current clinical evidence is conflicting
The Ozempic label permits an increase from 1 mg to 2 mg after at least four weeks when additional glycemic control is needed, but a higher dose is not automatically the correct response to a weight plateau